Xperi (XPER) Financials

$6.94 -0.03 (-0.43%)

Closing price 03:59 PM Eastern

Extended Trading

$6.94 -0.01 (-0.07%)

As of 05:06 PM Eastern

Annual Income Statements for Xperi

This table shows Xperi's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-138	-176	-757	-137	-14
Consolidated Net Income / (Loss)	-141	-179	-761	-140	-0.87
Net Income / (Loss) Continuing Operations	-141	-179	-761	-140	-0.87
Total Pre-Tax Income	-151	-160	-748	-130	12
Total Operating Income	-153	-162	-749	-130	-87
Total Gross Profit	298	361	379	403	380
Total Revenue	376	486	502	521	494
Operating Revenue	376	486	502	521	494
Total Cost of Revenue	78	126	123	119	114
Operating Cost of Revenue	78	126	123	119	114
Total Operating Expenses	451	523	1,129	532	467
Selling, General & Admin Expense	173	200	217	233	218
Research & Development Expense	163	195	216	223	191
Depreciation Expense	17	23	21	17	13
Amortization Expense	98	105	62	58	43
Impairment Charge	0.00	0.00	612	1.71	1.54
Total Other Income / (Expense), net	1.54	1.59	1.82	-0.01	99
Interest Expense	-	-	1.51	3.00	3.01
Interest & Investment Income	-	-	3.33	2.99	0.83
Other Income / (Expense), net	1.54	1.59	0.00	0.00	101
Income Tax Expense	-9.74	19	14	10	12
Net Income / (Loss) Attributable to Noncontrolling Interest	-2.97	-3.46	-3.72	-3.08	13
Basic Earnings per Share	($3.29)	($4.18)	($18.02)	($3.18)	($0.31)
Weighted Average Basic Shares Outstanding	42.02M	42.02M	42.03M	43.01M	45.06M
Diluted Earnings per Share	($3.29)	($4.18)	($18.02)	($3.18)	($0.31)
Weighted Average Diluted Shares Outstanding	42.02M	42.02M	42.03M	43.01M	45.06M
Weighted Average Basic & Diluted Shares Outstanding	-	-	42.08M	44.27M	44.39M

This table shows Xperi's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-401	-297	-32	-38	-41	-25	-13	-30	-17	46
Consolidated Net Income / (Loss)	-402	-298	-33	-39	-42	-25	-13	-31	-20	63
Net Income / (Loss) Continuing Operations	-402	-298	-33	-39	-42	-25	-13	-31	-20	63
Total Pre-Tax Income	-400	-297	-33	-34	-32	-30	-9.10	-21	-17	59
Total Operating Income	-399	-299	-34	-35	-31	-30	-32	-22	-19	-14
Total Gross Profit	90	98	99	96	104	104	89	91	105	95
Total Revenue	122	136	127	127	130	137	119	120	133	122
Operating Revenue	122	136	127	127	130	137	119	120	133	122
Total Cost of Revenue	31	37	28	31	26	34	30	29	27	28
Operating Cost of Revenue	31	37	28	31	26	34	30	29	27	28
Total Operating Expenses	489	397	133	131	135	133	121	113	124	109
Selling, General & Admin Expense	57	61	58	56	60	60	56	53	56	52
Research & Development Expense	57	58	55	56	56	56	50	45	54	42
Depreciation Expense	4.99	4.80	4.09	4.20	4.25	4.10	3.58	3.28	2.92	2.86
Amortization Expense	17	16	15	15	15	13	11	11	11	10
Impairment Charge	354	258	1.10	0.00	0.00	0.61	0.00	0.00	0.00	1.54
Total Other Income / (Expense), net	-0.53	2.12	0.37	0.91	-1.34	0.05	23	0.54	1.62	73
Interest Expense	-	-	0.74	0.75	1.34	0.17	0.75	0.75	0.76	0.76
Other Income / (Expense), net	-0.53	0.30	0.00	0.00	0.00	-	23	0.00	2.38	76
Income Tax Expense	2.02	1.09	-0.29	5.09	9.69	-4.44	4.27	9.27	2.90	-3.99
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.89	-1.02	-0.94	-0.97	-0.65	-0.52	-0.25	-0.33	-3.03	17
Basic Earnings per Share	($9.54)	($7.06)	($0.76)	($0.90)	($0.96)	($0.56)	($0.29)	($0.67)	($0.37)	$1.02
Weighted Average Basic Shares Outstanding	42.02M	42.03M	42.22M	42.77M	43.32M	43.01M	44.52M	45.33M	45.68M	45.06M
Diluted Earnings per Share	($9.54)	($7.06)	($0.76)	($0.90)	($0.96)	($0.56)	($0.29)	($0.67)	($0.37)	$1.02
Weighted Average Diluted Shares Outstanding	42.02M	42.03M	42.22M	42.77M	43.32M	43.01M	44.52M	45.33M	45.68M	45.06M
Weighted Average Basic & Diluted Shares Outstanding	-	42.08M	42.52M	43.30M	43.47M	44.27M	45.15M	45.81M	44.83M	44.39M

This table details how cash moves in and out of Xperi's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	38	35	39	-5.69	-24
Net Cash From Operating Activities	-24	-23	-28	0.06	-55
Net Cash From Continuing Operating Activities	-24	-23	-28	0.06	-55
Net Income / (Loss) Continuing Operations	-141	-179	-761	-140	-0.87
Consolidated Net Income / (Loss)	-141	-179	-761	-140	-0.87
Depreciation Expense	17	23	21	17	13
Amortization Expense	98	105	62	58	43
Non-Cash Adjustments To Reconcile Net Income	29	49	645	52	-83
Changes in Operating Assets and Liabilities, net	-26	-21	4.94	13	-27
Net Cash From Investing Activities	27	-21	-65	-13	51
Net Cash From Continuing Investing Activities	27	-21	-65	-13	51
Purchase of Property, Plant & Equipment	-6.60	-8.89	-14	-13	-17
Acquisitions	33	-13	-51	-0.19	-0.20
Divestitures	-	-	0.00	0.00	68
Net Cash From Financing Activities	34	83	136	7.05	-19
Net Cash From Continuing Financing Activities	34	83	136	7.05	-19
Repurchase of Common Equity	-	-	0.00	0.00	-20
Issuance of Common Equity	-	0.00	0.00	12	7.86
Other Financing Activities, net	34	83	136	-4.88	-7.22
Effect of Exchange Rate Changes	1.37	-3.33	-3.03	0.13	0.00
Cash Interest Paid	0.00	0.00	0.76	3.00	3.01
Cash Income Taxes Paid	8.58	12	13	21	19

This table details how cash moves in and out of Xperi's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	152	-125	-49	1.46	19	23	-59	-2.74	-20	58
Net Cash From Operating Activities	11	-17	-43	-1.53	24	21	-50	-2.13	-4.65	1.23
Net Cash From Continuing Operating Activities	11	-17	-43	-1.53	24	21	-50	-2.13	-4.65	1.23
Net Income / (Loss) Continuing Operations	-402	-298	-33	-39	-42	-25	-13	-31	-20	63
Consolidated Net Income / (Loss)	-402	-298	-33	-39	-42	-25	-13	-31	-20	63
Depreciation Expense	4.99	4.80	4.09	4.20	4.25	4.10	3.58	3.28	2.92	2.86
Amortization Expense	17	16	15	15	15	13	11	11	11	10
Non-Cash Adjustments To Reconcile Net Income	360	261	7.94	20	11	13	-13	-2.40	-6.24	-62
Changes in Operating Assets and Liabilities, net	31	-0.64	-37	-1.05	36	16	-39	17	7.57	-13
Net Cash From Investing Activities	-54	-3.75	-3.93	-2.27	-3.38	-3.35	-4.71	-3.73	-4.42	64
Net Cash From Continuing Investing Activities	47	-105	-3.93	-2.27	-3.38	-3.35	-4.71	-3.73	-4.42	64
Purchase of Property, Plant & Equipment	-3.36	-3.69	-3.86	-2.25	-3.32	-3.32	-4.45	-3.68	-4.35	-4.28
Acquisitions	50	-101	-0.07	-0.02	-0.06	-0.04	-0.27	-0.05	-0.07	0.19
Net Cash From Financing Activities	92	-0.29	-2.92	5.64	-1.19	5.52	-4.67	3.07	-11	-7.03
Net Cash From Continuing Financing Activities	92	-0.29	-2.92	5.64	-1.19	5.52	-4.67	3.07	-11	-7.03
Repurchase of Common Equity	-	-	-	-	-	-	-	-	-	-9.99
Issuance of Common Equity	-	-	0.00	5.85	-	6.08	0.00	4.33	-	3.53
Other Financing Activities, net	92	-0.29	-2.92	-0.21	-1.19	-0.56	-4.67	-1.26	-0.72	-0.57
Cash Interest Paid	-	0.76	1.50	-	0.75	0.76	0.76	0.75	0.75	0.76
Cash Income Taxes Paid	1.04	3.96	1.60	8.51	5.40	5.83	4.24	4.97	3.05	6.87

This table presents Xperi's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	1,229	737	674	668
Total Current Assets	277	332	317	305
Cash & Equivalents	121	160	142	131
Accounts Receivable	130	130	120	142
Prepaid Expenses	-	42	39	32
Other Current Nonoperating Assets	-	0.00	16	0.00
Plant, Property, & Equipment, net	57	48	42	44
Total Noncurrent Assets	894	357	315	318
Noncurrent Note & Lease Receivables	3.83	4.29	0.00	30
Intangible Assets	271	264	207	164
Noncurrent Deferred & Refundable Income Taxes	1.85	2.10	5.09	7.23
Other Noncurrent Operating Assets	81	86	91	118
Other Noncurrent Nonoperating Assets	-	0.00	12	0.00
Total Liabilities & Shareholders' Equity	1,229	737	674	668
Total Liabilities	213	288	287	239
Total Current Liabilities	120	150	165	185
Short-Term Debt	-	-	0.00	50
Accounts Payable	7.36	15	21	17
Accrued Expenses	84	110	110	94
Current Deferred Revenue	28	25	28	24
Other Current Nonoperating Liabilities	-	0.00	6.19	0.00
Total Noncurrent Liabilities	93	138	121	53
Long-Term Debt	0.00	50	50	0.00
Noncurrent Deferred Revenue	24	19	19	21
Noncurrent Deferred & Payable Income Tax Liabilities	14	13	6.98	1.49
Other Noncurrent Operating Liabilities	55	56	35	31
Other Noncurrent Nonoperating Liabilities	-	0.00	9.81	0.00
Commitments & Contingencies	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,016	449	387	429
Total Preferred & Common Equity	1,025	463	404	429
Preferred Stock	0.00	0.00	0.00	0.00
Total Common Equity	1,025	463	404	429
Common Stock	0.00	1,136	1,213	1,275
Retained Earnings	0.00	-669	-805	-839
Accumulated Other Comprehensive Income / (Loss)	-0.68	-4.12	-2.87	-6.08
Noncontrolling Interest	-9.21	-14	-17	0.00

This table presents Xperi's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	687	671	664	630	619	616
Total Current Assets	297	288	296	272	266	259
Cash & Equivalents	111	112	132	95	92	73
Accounts Receivable	140	136	125	134	138	147
Prepaid Expenses	-	40	39	43	36	38
Other Current Nonoperating Assets	-	-	-	0.00	0.00	1.31
Plant, Property, & Equipment, net	47	46	45	42	42	44
Total Noncurrent Assets	343	337	324	317	311	314
Noncurrent Note & Lease Receivables	9.56	17	22	44	29	29
Intangible Assets	250	235	220	196	185	174
Noncurrent Deferred & Refundable Income Taxes	2.28	2.40	2.47	4.89	4.95	5.06
Other Noncurrent Operating Assets	81	82	79	72	92	105
Other Noncurrent Nonoperating Assets	-	-	-	0.00	0.00	0.17
Total Liabilities & Shareholders' Equity	687	671	664	630	619	616
Total Liabilities	257	257	278	249	249	260
Total Current Liabilities	126	127	151	130	133	201
Short-Term Debt	-	-	-	-	-	50
Accounts Payable	14	11	16	20	14	19
Accrued Expenses	87	91	110	84	90	106
Current Deferred Revenue	25	25	26	26	28	26
Other Current Nonoperating Liabilities	-	-	-	0.00	0.00	0.07
Total Noncurrent Liabilities	131	130	126	119	117	59
Long-Term Debt	50	50	50	50	50	0.00
Noncurrent Deferred Revenue	19	18	19	23	22	20
Noncurrent Deferred & Payable Income Tax Liabilities	13	12	12	7.01	7.00	7.02
Other Noncurrent Operating Liabilities	49	49	45	39	37	32
Other Noncurrent Nonoperating Liabilities	-	-	-	0.00	0.00	0.01
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	431	414	386	382	370	356
Total Preferred & Common Equity	446	431	403	399	389	377
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	446	431	403	399	389	377
Common Stock	1,149	1,173	1,189	1,222	1,242	1,256
Retained Earnings	-701	-739	-781	-819	-849	-876
Accumulated Other Comprehensive Income / (Loss)	-2.64	-3.17	-5.49	-4.04	-4.38	-3.34
Noncontrolling Interest	-15	-16	-17	-17	-19	-22

This table displays calculated financial ratios and metrics derived from Xperi's official financial filings.

Metric	2020	2021	2022	2023	2024
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-
Revenue Growth	0.00%	29.35%	3.24%	3.80%	-5.30%
EBITDA Growth	0.00%	10.54%	-1,961.41%	91.71%	226.31%
EBIT Growth	0.00%	-6.10%	-367.70%	82.70%	110.61%
NOPAT Growth	0.00%	-6.07%	-363.10%	82.70%	107.20%
Net Income Growth	0.00%	-26.74%	-325.07%	81.65%	99.38%
EPS Growth	0.00%	-27.05%	-331.10%	82.35%	90.25%
Operating Cash Flow Growth	0.00%	1.36%	-21.29%	100.22%	-89,358.06%
Free Cash Flow Firm Growth	0.00%	0.00%	103.15%	-209.51%	-69.54%
Invested Capital Growth	0.00%	0.00%	-62.15%	-16.50%	23.18%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.33%	-2.92%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	82.69%	510.71%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	67.33%	117.80%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	67.50%	109.10%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	66.13%	99.03%
EPS Q/Q Growth	0.00%	0.00%	0.00%	67.15%	83.60%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	100.16%	-54.12%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	40.13%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	-7.21%	5.06%
Profitability Metrics	-	-	-	-	-
Gross Margin	79.32%	74.18%	75.52%	77.25%	76.96%
EBITDA Margin	-9.61%	-6.65%	-132.74%	-10.60%	14.13%
Operating Margin	-40.56%	-33.26%	-149.21%	-24.87%	-17.64%
EBIT Margin	-40.16%	-32.94%	-149.21%	-24.87%	2.79%
Profit (Net Income) Margin	-37.57%	-36.81%	-151.56%	-26.79%	-0.18%
Tax Burden Percent	93.55%	111.76%	101.82%	107.75%	-7.51%
Interest Burden Percent	100.00%	100.00%	99.76%	100.01%	84.16%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	107.51%
Return on Invested Capital (ROIC)	0.00%	-25.31%	-85.02%	-29.19%	2.07%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	83.73%	119.99%	16.48%	10.08%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-9.95%	-18.91%	-4.23%	-2.28%
Return on Equity (ROE)	0.00%	-35.25%	-103.92%	-33.41%	-0.21%
Cash Return on Invested Capital (CROIC)	0.00%	-225.31%	5.15%	-11.20%	-18.70%
Operating Return on Assets (OROA)	0.00%	-13.04%	-76.25%	-18.38%	2.05%
Return on Assets (ROA)	0.00%	-14.57%	-77.45%	-19.81%	-0.13%
Return on Common Equity (ROCE)	0.00%	-35.57%	-105.60%	-34.67%	-0.22%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-17.47%	-164.26%	-34.56%	-0.20%
Net Operating Profit after Tax (NOPAT)	-107	-113	-525	-91	6.53
NOPAT Margin	-28.40%	-23.29%	-104.45%	-17.41%	1.32%
Net Nonoperating Expense Percent (NNEP)	0.00%	-109.03%	-205.01%	-45.67%	-8.01%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-105.13%	-20.76%	1.36%
Cost of Revenue to Revenue	20.68%	25.82%	24.48%	22.75%	23.04%
SG&A Expenses to Revenue	45.89%	41.10%	43.28%	44.77%	44.18%
R&D to Revenue	43.45%	40.06%	43.08%	42.74%	38.76%
Operating Expenses to Revenue	119.88%	107.44%	224.73%	102.11%	94.60%
Earnings before Interest and Taxes (EBIT)	-151	-160	-749	-130	14
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-36	-32	-667	-55	70
Valuation Ratios	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.78	1.15	1.01
Price to Tangible Book Value (P/TBV)	0.00	0.00	1.82	2.35	1.63
Price to Revenue (P/Rev)	0.00	0.00	0.72	0.89	0.87
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00
Dividend Yield	2.41%	1.12%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.70	1.25	1.01
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.47	0.68	0.71
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	5.03
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	25.51
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	53.71
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	5,708.36	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	7.46	0.00	0.00
Leverage & Solvency	-	-	-	-	-
Debt to Equity	0.00	0.00	0.11	0.13	0.12
Long-Term Debt to Equity	0.00	0.00	0.11	0.13	0.00
Financial Leverage	0.00	-0.12	-0.16	-0.26	-0.23
Leverage Ratio	0.00	1.21	1.34	1.69	1.64
Compound Leverage Factor	0.00	1.21	1.34	1.69	1.38
Debt to Total Capital	0.00%	0.00%	10.02%	11.44%	10.44%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	10.44%
Long-Term Debt to Total Capital	0.00%	0.00%	10.02%	11.44%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	-0.91%	-2.89%	-3.91%	0.00%
Common Equity to Total Capital	0.00%	100.91%	92.87%	92.47%	89.56%
Debt to EBITDA	0.00	0.00	-0.08	-0.91	0.72
Net Debt to EBITDA	0.00	0.00	0.17	1.67	-1.15
Long-Term Debt to EBITDA	0.00	0.00	-0.08	-0.91	0.00
Debt to NOPAT	0.00	0.00	-0.10	-0.55	7.65
Net Debt to NOPAT	0.00	0.00	0.21	1.01	-12.33
Long-Term Debt to NOPAT	0.00	0.00	-0.10	-0.55	0.00
Altman Z-Score	0.00	0.00	-2.89	-0.29	0.35
Noncontrolling Interest Sharing Ratio	0.00%	-0.91%	-1.61%	-3.77%	-2.09%
Liquidity Ratios	-	-	-	-	-
Current Ratio	0.00	2.31	2.21	1.92	1.64
Quick Ratio	0.00	2.09	1.93	1.59	1.47
Cash Flow Metrics	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-1,009	32	-35	-59
Operating Cash Flow to CapEx	-360.20%	-263.72%	-200.22%	0.49%	-330.23%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	21.03	-11.61	-19.63
Operating Cash Flow to Interest Expense	0.00	0.00	-18.81	0.02	-18.40
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	-28.21	-4.23	-23.97
Efficiency Ratios	-	-	-	-	-
Asset Turnover	0.00	0.40	0.51	0.74	0.74
Accounts Receivable Turnover	0.00	3.73	3.86	4.17	3.77
Inventory Turnover	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	8.46	9.54	11.66	11.48
Accounts Payable Turnover	0.00	17.06	11.06	6.64	6.01
Days Sales Outstanding (DSO)	0.00	97.88	94.63	87.54	96.82
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	21.39	32.99	54.94	60.69
Cash Conversion Cycle (CCC)	0.00	76.49	61.63	32.60	36.13
Capital & Investment Metrics	-	-	-	-	-
Invested Capital	0.00	895	339	283	349
Invested Capital Turnover	0.00	1.09	0.81	1.68	1.56
Increase / (Decrease) in Invested Capital	0.00	895	-556	-56	66
Enterprise Value (EV)	0.00	0.00	237	354	351
Market Capitalization	0.00	0.00	362	463	432
Book Value per Share	$0.00	$24.39	$11.03	$9.30	$9.57
Tangible Book Value per Share	$0.00	$5.18	$4.74	$4.54	$5.92
Total Capital	0.00	1,016	499	437	479
Total Debt	0.00	0.00	50	50	50
Total Long-Term Debt	0.00	0.00	50	50	0.00
Net Debt	0.00	-121	-110	-92	-81
Capital Expenditures (CapEx)	6.60	8.89	14	13	17
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	36	22	9.72	39
Debt-free Net Working Capital (DFNWC)	0.00	157	182	152	170
Net Working Capital (NWC)	0.00	157	182	152	120
Net Nonoperating Expense (NNE)	34	66	237	49	7.40
Net Nonoperating Obligations (NNO)	0.00	-121	-110	-104	-81
Total Depreciation and Amortization (D&A)	115	128	83	74	56
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	7.50%	4.36%	1.86%	7.89%
Debt-free Net Working Capital to Revenue	0.00%	32.31%	36.24%	29.12%	34.34%
Net Working Capital to Revenue	0.00%	32.31%	36.24%	29.12%	24.21%
Earnings Adjustments	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	($18.02)	($3.18)	($0.31)
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	42.03M	43.01M	45.06M
Adjusted Diluted Earnings per Share	$0.00	$0.00	($18.02)	($3.18)	($0.31)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	42.03M	43.01M	45.06M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	42.08M	44.27M	44.39M
Normalized Net Operating Profit after Tax (NOPAT)	-107	-113	-96	-90	-60
Normalized NOPAT Margin	-28.40%	-23.29%	-19.12%	-17.18%	-12.13%
Pre Tax Income Margin	-40.16%	-32.94%	-148.85%	-24.87%	2.35%
Debt Service Ratios	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	-495.66	-43.21	4.57
NOPAT to Interest Expense	0.00	0.00	-346.96	-30.25	2.17
EBIT Less CapEx to Interest Expense	0.00	0.00	-505.05	-47.46	-1.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	-356.36	-34.50	-3.40
Payout Ratios	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	-2,300.35%

This table displays calculated financial ratios and metrics derived from Xperi's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.00%	6.69%	0.53%	7.20%	1.26%	-6.30%	-5.74%	1.92%	-10.84%
EBITDA Growth	0.00%	0.00%	-82.24%	-504.26%	96.81%	95.58%	135.62%	53.11%	80.76%	705.41%
EBIT Growth	0.00%	0.00%	-18.27%	-55.79%	92.23%	90.02%	72.05%	37.73%	47.91%	305.46%
NOPAT Growth	0.00%	0.00%	-16.16%	-57.82%	92.22%	90.03%	3.79%	37.73%	40.24%	26.89%
Net Income Growth	0.00%	0.00%	-8.03%	-27.07%	89.53%	91.51%	59.41%	22.19%	52.86%	348.74%
EPS Growth	0.00%	0.00%	-8.57%	-25.00%	89.94%	92.07%	61.84%	25.56%	61.46%	282.14%
Operating Cash Flow Growth	0.00%	0.00%	-134.71%	60.77%	120.03%	220.74%	-15.51%	-39.84%	-119.34%	-94.05%
Free Cash Flow Firm Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	102.72%	102.47%	87.82%	-330.54%
Invested Capital Growth	0.00%	0.00%	0.00%	0.00%	0.00%	-16.50%	-9.01%	-7.00%	8.79%	23.18%
Revenue Q/Q Growth	-3.62%	11.42%	-6.41%	0.03%	2.77%	5.25%	-13.40%	0.63%	11.12%	-7.92%
EBITDA Q/Q Growth	-14,017.44%	26.49%	94.68%	-10.22%	25.36%	-1.81%	142.70%	-245.07%	69.37%	3,303.66%
EBIT Q/Q Growth	-1,669.77%	25.25%	88.68%	-4.71%	11.74%	4.02%	68.43%	-133.23%	26.16%	478.55%
NOPAT Q/Q Growth	-1,690.43%	25.07%	88.76%	-4.71%	11.74%	4.02%	-8.47%	32.23%	15.30%	-17.43%
Net Income Q/Q Growth	-1,196.70%	25.80%	88.95%	-19.51%	-6.88%	39.83%	47.18%	-129.09%	35.26%	417.50%
EPS Q/Q Growth	-1,225.00%	26.00%	89.24%	-18.42%	-6.67%	41.67%	48.21%	-131.03%	44.78%	375.68%
Operating Cash Flow Q/Q Growth	380.75%	-256.69%	-151.89%	96.46%	1,674.71%	-14.02%	-340.97%	95.71%	-117.81%	126.44%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	4.20%	13.32%	110.73%	-69.46%	-12.99%	-527.13%	-103.10%
Invested Capital Q/Q Growth	0.00%	0.00%	9.15%	-4.77%	-13.44%	-7.21%	18.95%	-2.66%	1.26%	5.06%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	74.18%	72.51%	78.09%	75.68%	79.74%	75.54%	74.96%	75.79%	79.32%	77.47%
EBITDA Margin	-310.81%	-205.06%	-11.57%	-12.75%	-9.26%	-8.96%	4.40%	-6.34%	-1.75%	60.85%
Operating Margin	-328.14%	-220.67%	-26.49%	-27.73%	-23.81%	-21.72%	-27.20%	-18.32%	-13.96%	-11.68%
EBIT Margin	-328.57%	-220.44%	-26.49%	-27.73%	-23.81%	-21.72%	-7.90%	-18.32%	-12.17%	50.04%
Profit (Net Income) Margin	-330.24%	-219.91%	-25.97%	-31.03%	-32.27%	-18.45%	-11.25%	-25.61%	-14.92%	51.46%
Tax Burden Percent	100.51%	100.37%	99.12%	114.85%	129.90%	85.08%	146.95%	143.37%	117.12%	106.76%
Interest Burden Percent	100.00%	99.39%	98.90%	97.42%	104.30%	99.83%	96.87%	97.53%	104.67%	96.31%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-6.76%
Return on Invested Capital (ROIC)	0.00%	-228.95%	-51.16%	-56.31%	-56.82%	-25.49%	-27.67%	-19.09%	-15.61%	-19.49%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-148.41%	-20.12%	-8.89%	-6.93%	-21.34%	-45.16%	10.15%	-2.66%	-104.16%
Return on Net Nonoperating Assets (RNNOA)	0.00%	36.40%	2.84%	1.33%	1.46%	5.47%	5.89%	-1.35%	0.38%	23.58%
Return on Equity (ROE)	0.00%	-192.55%	-48.32%	-54.97%	-55.35%	-20.02%	-21.79%	-20.44%	-15.24%	4.09%
Cash Return on Invested Capital (CROIC)	0.00%	9.38%	0.00%	0.00%	0.00%	-11.20%	-16.00%	-16.45%	-30.98%	-18.70%
Operating Return on Assets (OROA)	0.00%	-112.66%	-19.67%	-21.11%	-18.63%	-16.05%	-6.16%	-14.37%	-9.67%	36.84%
Return on Assets (ROA)	0.00%	-112.38%	-19.28%	-23.62%	-25.24%	-13.63%	-8.77%	-20.09%	-11.85%	37.88%
Return on Common Equity (ROCE)	0.00%	-195.65%	-50.05%	-57.14%	-57.75%	-20.78%	-22.66%	-21.35%	-16.02%	4.17%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	-171.25%	-179.24%	-102.29%	0.00%	-30.09%	-28.65%	-23.62%	0.00%
Net Operating Profit after Tax (NOPAT)	-279	-209	-24	-25	-22	-21	-23	-15	-13	-15
NOPAT Margin	-229.70%	-154.47%	-18.54%	-19.41%	-16.67%	-15.20%	-19.04%	-12.82%	-9.77%	-12.46%
Net Nonoperating Expense Percent (NNEP)	0.00%	-80.54%	-31.03%	-47.42%	-49.89%	-4.15%	17.48%	-29.24%	-12.96%	84.67%
Return On Investment Capital (ROIC_SIMPLE)	-	-41.96%	-	-	-	-4.77%	-	-	-	-3.18%
Cost of Revenue to Revenue	25.82%	27.49%	21.91%	24.32%	20.26%	24.46%	25.04%	24.21%	20.68%	22.53%
SG&A Expenses to Revenue	46.62%	44.64%	45.55%	44.53%	45.72%	43.36%	47.42%	44.40%	42.50%	42.63%
R&D to Revenue	46.92%	42.58%	43.25%	43.90%	43.28%	40.69%	42.44%	37.73%	40.35%	34.46%
Operating Expenses to Revenue	402.32%	293.18%	104.58%	103.41%	103.56%	97.26%	102.16%	94.11%	93.28%	89.15%
Earnings before Interest and Taxes (EBIT)	-400	-299	-34	-35	-31	-30	-9.39	-22	-16	61
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-378	-278	-15	-16	-12	-12	5.23	-7.59	-2.32	74
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.78	1.03	1.28	1.03	1.15	1.27	0.89	1.03	1.01
Price to Tangible Book Value (P/TBV)	0.00	1.82	2.34	2.82	2.27	2.35	2.49	1.69	1.91	1.63
Price to Revenue (P/Rev)	0.00	0.72	0.90	1.08	0.80	0.89	0.99	0.68	0.76	0.87
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.70	1.04	1.35	1.04	1.25	1.32	0.87	1.04	1.01
Enterprise Value to Revenue (EV/Rev)	0.00	0.47	0.75	0.93	0.61	0.68	0.87	0.56	0.68	0.71
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	5.03
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	25.51
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	53.71
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	5,708.36	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.11	0.12	0.12	0.13	0.13	0.13	0.14	0.14	0.12
Long-Term Debt to Equity	0.00	0.11	0.12	0.12	0.13	0.13	0.13	0.14	0.00	0.00
Financial Leverage	0.00	-0.25	-0.14	-0.15	-0.21	-0.26	-0.13	-0.13	-0.14	-0.23
Leverage Ratio	0.00	1.34	1.60	1.62	1.72	1.69	1.62	1.64	1.73	1.64
Compound Leverage Factor	0.00	1.33	1.58	1.58	1.79	1.68	1.57	1.60	1.81	1.58
Debt to Total Capital	0.00%	10.02%	10.40%	10.77%	11.46%	11.44%	11.58%	11.90%	12.32%	10.44%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	12.32%	10.44%
Long-Term Debt to Total Capital	0.00%	10.02%	10.40%	10.77%	11.46%	11.44%	11.58%	11.90%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	-2.89%	-3.20%	-3.52%	-3.83%	-3.91%	-4.03%	-4.44%	-5.32%	0.00%
Common Equity to Total Capital	0.00%	92.87%	92.79%	92.75%	92.38%	92.47%	92.45%	92.54%	93.00%	89.56%
Debt to EBITDA	0.00	-0.08	-0.07	-0.07	-0.16	-0.91	-1.41	-1.87	-2.94	0.72
Net Debt to EBITDA	0.00	0.17	0.09	0.09	0.26	1.67	1.28	1.59	1.34	-1.15
Long-Term Debt to EBITDA	0.00	-0.08	-0.07	-0.07	-0.16	-0.91	-1.41	-1.87	0.00	0.00
Debt to NOPAT	0.00	-0.10	-0.09	-0.09	-0.18	-0.55	-0.56	-0.62	-0.70	7.65
Net Debt to NOPAT	0.00	0.21	0.12	0.12	0.29	1.01	0.50	0.53	0.32	-12.33
Long-Term Debt to NOPAT	0.00	-0.10	-0.09	-0.09	-0.18	-0.55	-0.56	-0.62	0.00	0.00
Altman Z-Score	0.00	-0.88	0.53	0.63	0.14	0.19	0.44	-0.13	-0.24	0.58
Noncontrolling Interest Sharing Ratio	0.00%	-1.61%	-3.57%	-3.94%	-4.33%	-3.77%	-4.03%	-4.46%	-5.16%	-2.09%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.00	2.21	2.37	2.26	1.95	1.92	2.10	2.01	1.29	1.64
Quick Ratio	0.00	1.93	1.99	1.95	1.70	1.59	1.77	1.74	1.09	1.47
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	0.00	-393	-377	-327	35	11	9.32	-40	-81
Operating Cash Flow to CapEx	324.64%	-463.36%	-1,116.37%	-67.91%	722.92%	623.07%	-1,119.31%	-57.93%	-106.92%	28.72%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	-531.62	-502.50	-244.51	201.49	14.32	12.46	-52.64	-106.92
Operating Cash Flow to Interest Expense	0.00	0.00	-58.25	-2.03	17.99	118.74	-66.56	-2.85	-6.15	1.63
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	-63.46	-5.03	15.50	99.68	-72.51	-7.78	-11.90	-4.03
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.51	0.74	0.76	0.78	0.74	0.78	0.78	0.79	0.74
Accounts Receivable Turnover	0.00	3.86	3.65	3.76	4.15	4.17	3.75	3.70	3.73	3.77
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	9.54	10.84	11.02	11.65	11.66	11.56	11.42	11.54	11.48
Accounts Payable Turnover	0.00	11.06	8.97	11.10	7.85	6.64	7.21	9.21	6.87	6.01
Days Sales Outstanding (DSO)	0.00	94.63	100.03	97.12	88.03	87.54	97.35	98.63	97.78	96.82
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	32.99	40.71	32.89	46.48	54.94	50.64	39.65	53.16	60.69
Cash Conversion Cycle (CCC)	0.00	61.63	59.32	64.23	41.55	32.60	46.71	58.98	44.63	36.13
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	0.00	339	370	352	305	283	337	328	332	349
Invested Capital Turnover	0.00	1.48	2.76	2.90	3.41	1.68	1.45	1.49	1.60	1.56
Increase / (Decrease) in Invested Capital	0.00	0.00	370	352	305	-56	-33	-25	27	66
Enterprise Value (EV)	0.00	237	383	474	316	354	444	284	344	351
Market Capitalization	0.00	362	459	553	414	463	507	345	388	432
Book Value per Share	$0.00	$11.03	$10.60	$10.13	$9.31	$9.30	$9.02	$8.61	$8.24	$9.57
Tangible Book Value per Share	$0.00	$4.74	$4.66	$4.60	$4.22	$4.54	$4.59	$4.51	$4.44	$5.92
Total Capital	0.00	499	481	464	436	437	432	420	406	479
Total Debt	0.00	50	50	50	50	50	50	50	50	50
Total Long-Term Debt	0.00	50	50	50	50	50	50	50	0.00	0.00
Net Debt	0.00	-110	-61	-62	-82	-92	-45	-42	-23	-81
Capital Expenditures (CapEx)	3.36	3.69	3.86	2.25	3.32	3.32	4.45	3.68	4.35	4.28
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	22	61	49	13	9.72	47	41	35	39
Debt-free Net Working Capital (DFNWC)	0.00	182	172	161	144	152	143	134	108	170
Net Working Capital (NWC)	0.00	182	172	161	144	152	143	134	58	120
Net Nonoperating Expense (NNE)	122	89	9.42	15	20	4.45	-9.26	15	6.84	-78
Net Nonoperating Obligations (NNO)	0.00	-110	-61	-62	-82	-104	-45	-42	-24	-81
Total Depreciation and Amortization (D&A)	22	21	19	19	19	18	15	14	14	13
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	4.36%	11.95%	9.53%	2.46%	1.86%	9.23%	8.18%	6.85%	7.89%
Debt-free Net Working Capital to Revenue	0.00%	36.24%	33.64%	31.49%	27.77%	29.12%	27.78%	26.46%	21.14%	34.34%
Net Working Capital to Revenue	0.00%	36.24%	33.64%	31.49%	27.77%	29.12%	27.78%	26.46%	11.31%	24.21%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	($7.06)	($0.76)	($0.90)	($0.96)	($0.56)	($0.29)	($0.67)	($0.37)	$1.02
Adjusted Weighted Average Basic Shares Outstanding	0.00	42.03M	42.22M	42.77M	43.32M	43.01M	44.52M	45.33M	45.68M	45.06M
Adjusted Diluted Earnings per Share	$0.00	($7.06)	($0.76)	($0.90)	($0.96)	($0.56)	($0.29)	($0.67)	($0.37)	$1.02
Adjusted Weighted Average Diluted Shares Outstanding	0.00	42.03M	42.22M	42.77M	43.32M	43.01M	44.52M	45.33M	45.68M	45.06M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	42.08M	42.52M	43.30M	43.47M	44.27M	45.15M	45.81M	44.83M	44.39M
Normalized Net Operating Profit after Tax (NOPAT)	-32	-29	-23	-25	-22	-20	-23	-15	-13	-8.93
Normalized NOPAT Margin	-25.98%	-21.07%	-17.94%	-19.41%	-16.67%	-14.89%	-19.04%	-12.82%	-9.77%	-7.29%
Pre Tax Income Margin	-328.57%	-219.10%	-26.20%	-27.01%	-24.84%	-21.68%	-7.66%	-17.87%	-12.74%	48.20%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	-45.41	-46.91	-23.24	-171.28	-12.56	-29.29	-21.40	81.00
NOPAT to Interest Expense	0.00	0.00	-31.78	-32.84	-16.27	-119.90	-30.25	-20.50	-17.18	-20.18
EBIT Less CapEx to Interest Expense	0.00	0.00	-50.62	-49.91	-25.73	-190.34	-18.50	-34.21	-27.15	75.34
NOPAT Less CapEx to Interest Expense	0.00	0.00	-37.00	-35.83	-18.76	-138.95	-36.20	-25.43	-22.93	-25.84
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-2,300.35%

Financials Breakdown Chart

Key Financial Trends

Here are the standout trends for Xperi (XPER) based on quarterly data from the last four years, focusing on the latest four quarters in 2024 and the preceding years for context.

Q4 2024 net income attributable to common shareholders was $46.22 million, marking a strong quarterly return to profitability.
Q4 2024 gross margin was about 77% (Gross Profit $94.80M on Revenue $122.36M), indicating solid core profitability.
Q4 2024 non-operating income significantly boosted overall results, with Total Other Income / (Expense), net totaling about $73.26M pre-tax.
Debt management improved in 2024, with long-term debt effectively reduced to zero by Q3 2024 (down from $50M earlier in the year).
Q4 2024 operating cash flow turned positive, with Net cash from continuing operating activities around $1.23M, signaling improved cash generation from operations.
Q4 2024 earnings per share (EPS) were $1.02 for both basic and diluted, on roughly 44.4M–45.1M shares outstanding, reinforcing per-share profitability.
Revenue in Q4 2024 declined about 11% year over year to $122.36M from $137.23M in Q4 2023, indicating top-line pressure despite the quarterly earnings rebound.
Historical impairments weighed on earnings in 2022 (Q3 2022 impairment $354.0M; Q4 2022 impairment $258.3M), contributing to a prolonged earnings headwind in that period.
In 2024, several quarters showed net losses (e.g., Q2 2024 net income −$30.63M; Q3 2024 net income −$19.83M), underscoring earnings volatility despite the Q4 rebound.
Balance sheet remains solid but steady rather than growth-oriented: total assets around $616M–$630M and total equity generally in the mid-$300M range across 2024 quarters, suggesting stable capitalization without clear multi-year asset growth yet.

05/05/26 05:58 PM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Xperi's Financials

When does Xperi's financial year end?

According to the most recent income statement we have on file, Xperi's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Xperi's net income changed over the last 4 years?

Xperi's net income appears to be on a downward trend, with a most recent value of -$869 thousand in 2024, falling from -$141.29 million in 2020. The previous period was -$139.69 million in 2023. Find out what analysts predict for Xperi in the coming months.

What is Xperi's operating income?

Xperi's total operating income in 2024 was -$87.08 million, based on the following breakdown:

Total Gross Profit: $379.93 million
Total Operating Expenses: $467.01 million

How has Xperi's revenue changed over the last 4 years?

Over the last 4 years, Xperi's total revenue changed from $376.10 million in 2020 to $493.69 million in 2024, a change of 31.3%.

How much debt does Xperi have?

Xperi's total liabilities were at $238.68 million at the end of 2024, a 16.7% decrease from 2023, and a 12.2% increase since 2021.

How much cash does Xperi have?

In the past 3 years, Xperi's cash and equivalents has ranged from $120.70 million in 2021 to $160.13 million in 2022, and is currently $130.56 million as of their latest financial filing in 2024.

How has Xperi's book value per share changed over the last 4 years?

Over the last 4 years, Xperi's book value per share changed from 0.00 in 2020 to 9.57 in 2024, a change of 957.1%.

Related Companies

Financial statements for NYSE:XPER last updated on 4/6/2025 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Xperi (XPER) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Xperi's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Xperi (XPER) Financials

Annual Income Statements for Xperi

Quarterly Income Statements for Xperi

Annual Cash Flow Statements for Xperi

Quarterly Cash Flow Statements for Xperi

Annual Balance Sheets for Xperi

Quarterly Balance Sheets for Xperi

Annual Metrics And Ratios for Xperi

Quarterly Metrics And Ratios for Xperi

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Xperi's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools